Bromfenac Sodium
6 NDCs across 6 manufacturers|5 Generic,1 Brand
Bromfenac Sodium is used to treat eye pain, inflammation and postoperative pain, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 24, 2005, and the first generic was approved May 11, 2011. FDA's Orange Book lists 7 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $69 million on Bromfenac Sodium across 261,000 claims for 143,000 beneficiaries.
Bromfenac Sodium is available as 6 NDCs from 6 manufacturers (5 generic, 1 brand), with NADAC prices from $13.25 to $115.55 per ML — the most expensive product costs about 8.7× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
5G / 1B
Manufacturers
6
competing in market
Price Spread
$13.25 – $115.55
per ML
7d Activity
avg +3.9% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Bausch & Lomb Incorporated manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Nonsteroidal Anti-inflammatory Drug class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
6 manufacturers producing BROMFENAC SODIUM(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PROLENSA 0.07% EYE DROPS | $115.5543 per ML | +0.02% |
BROMFENAC SODIUM 0.07% EYE DRP | $13.2497 per ML | +4.64% |
BROMFENAC SODIUM 0.07% EYE DRP | $13.2497 per ML | +4.64% |
BROMFENAC SODIUM 0.07% EYE DRP | $13.2497 per ML | +4.64% |
BROMFENAC SODIUM 0.07% EYE DRP | $13.2497 per ML | +4.64% |
BROMFENAC SODIUM 0.07% EYE DRP | $13.2497 per ML | +4.64% |
Frequently Asked Questions
What is Bromfenac Sodium used to treat?
Bromfenac Sodium is used to treat eye pain, inflammation and postoperative pain, per the National Library of Medicine's MED-RT classification.
When did Bromfenac Sodium become available as a generic?
FDA approved the first generic Bromfenac Sodium (ANDA) on May 11, 2011. The Orange Book currently lists 7 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Bromfenac Sodium?
In 2024, Medicare Part D spent $69 million on Bromfenac Sodium across 261,000 claims for 143,000 beneficiaries.
How many Bromfenac Sodium products are on the market?
The Bromfenac Sodium drug market contains 6 NDCs from 6 manufacturers — 5 generic and 1 brand product.
What is the price range for Bromfenac Sodium?
NADAC reference prices for Bromfenac Sodium range from $13.2497 to $115.5543 per ML — the most expensive product costs about 8.7× the cheapest.
Is generic Bromfenac Sodium cheaper than brand?
The average generic NADAC for Bromfenac Sodium is $13.2497 per ML, versus $115.5543 for brand-labeled products — brand versions average about 8.7× the generic price.
Which manufacturers make Bromfenac Sodium?
6 manufacturers list Bromfenac Sodium in NADAC. Ranked by number of NDCs, the largest are Bausch & Lomb Incorporated (1), Apotex Corp. (1), Alembic Pharmaceuticals Inc. (1), Lupin Pharmaceuticals Inc. (1), Dr. Reddy's Laboratories Inc. (1).
How has the price of Bromfenac Sodium changed recently?
Over the past 7 days, 6 Bromfenac Sodium NDCs rose and 0 fell, with a market-wide average change of +3.9%.